As of Oct 18
| +5.21 / +36.03%|
The 2 analysts offering 12-month price forecasts for Spectrum Pharmaceuticals Inc have a median target of 16.50, with a high estimate of 20.00 and a low estimate of 13.00. The median estimate represents a -16.12% decrease from the last price of 19.67.
The current consensus among 2 polled investment analysts is to Buy stock in Spectrum Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.